Can-Fite BioPharma Ltd. (CANF)

Can-Fite BioPharma Statistics

Total Valuation

CANF has a market cap or net worth of $15.39 million. The enterprise value is $7.39 million.

Market Cap	15.39M
Enterprise Value	7.39M

Important Dates

The next estimated earnings date is Tuesday, May 20, 2025, before market open.

Earnings Date	May 20, 2025
Ex-Dividend Date	n/a

Share Statistics

CANF has 3.11 billion shares outstanding. The number of shares has increased by 70.22% in one year.

Current Share Class	n/a
Shares Outstanding	3.11B
Shares Change (YoY)	+70.22%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.89B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.84
Forward PS	n/a
PB Ratio	2.83
P/TBV Ratio	2.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	10.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.38, with a Debt / Equity ratio of 0.02.

Current Ratio	4.38
Quick Ratio	3.84
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -134.94% and return on invested capital (ROIC) is -85.96%.

Return on Equity (ROE)	-134.94%
Return on Assets (ROA)	-53.18%
Return on Invested Capital (ROIC)	-85.96%
Return on Capital Employed (ROCE)	-115.03%
Revenue Per Employee	$134,800
Profits Per Employee	-$1.58M
Employee Count	5
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.37% in the last 52 weeks. The beta is 0.25, so CANF's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	-47.37%
50-Day Moving Average	1.39
200-Day Moving Average	1.89
Relative Strength Index (RSI)	39.32
Average Volume (20 Days)	449,710

Short Selling Information

Short Interest	307,989
Short Previous Month	378,889
Short % of Shares Out	2.40%
Short % of Float	n/a
Short Ratio (days to cover)	0.77

Income Statement

In the last 12 months, CANF had revenue of $674,000 and -$7.88 million in losses. Loss per share was -$0.00.

Revenue	674,000
Gross Profit	674,000
Operating Income	-8.13M
Pretax Income	-7.63M
Net Income	-7.88M
EBITDA	-8.12M
EBIT	-8.13M
Loss Per Share	-$0.00

Balance Sheet

The company has $7.89 million in cash and $104,000 in debt, giving a net cash position of $7.78 million or $0.00 per share.

Cash & Cash Equivalents	7.89M
Total Debt	104,000
Net Cash	7.78M
Net Cash Per Share	$0.00
Equity (Book Value)	5.44M
Book Value Per Share	0.00
Working Capital	6.93M

Cash Flow

In the last 12 months, operating cash flow was -$7.64 million and capital expenditures -$5,000, giving a free cash flow of -$7.64 million.

Operating Cash Flow	-7.64M
Capital Expenditures	-5,000
Free Cash Flow	-7.64M
FCF Per Share	-$0.00

Margins

Gross Margin	100.00%
Operating Margin	-1,206.23%
Pretax Margin	-1,169.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CANF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-70.22%
Shareholder Yield	-70.22%
Earnings Yield	-51.19%
FCF Yield	-49.64%

Analyst Forecast

The average price target for CANF is $14.00, which is 1,172.73% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	1,172.73%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 9, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jan 9, 2023
Split Type	Reverse
Split Ratio	0.1:1

Scores

CANF has an Altman Z-Score of -25.3 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-25.3
Piotroski F-Score	1